Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 256 results found. Search for [ COVID-19 vaccine trials China ]

Results 20 to 40 of 256
BusinessToday.In
January 4, 2021
Coronavirus vaccine: China has not done any efficacy trials, Russia also has not done any efficacy trials. We are doing efficacy trials on 26,000 people in the third phase, he said


Reuters
January 3, 2021
India on Sunday granted emergency approval to Bharat Biotech's COVAXIN but faced questions after taking the step without publishing efficacy data for the homegrown coronavirus vaccine


PTI
December 31, 2020
The researchers said this demonstrates 94.1 per cent efficacy in preventing symptomatic COVID-19, adding that cases of severe disease occurred only in participants who received the placebo


Reuters
December 30, 2020
The result is based on interim analysis of data from its Phase III clinical trial


PTI
December 27, 2020
Dalal Street witnessed gut-churning fluctuations, with the BSE Sensex swinging between historic losses and eye-popping gains, sometimes in the same session


Reuters
December 24, 2020
Brazil is the first country to complete a late-stage trial of the vaccine, called CoronaVac, but a release of the results, first set for early December, has now been delayed three times


PTI
December 20, 2020
Spokespeople for Pfizer, Moderna and AstraZeneca have said that pork products are not part of their COVID-19 vaccines. But limited supply and preexisting deals worth millions of dollars with other companies means that some countries with large Muslim populations, such as Indonesia, will receive vaccines that have not yet been certified to be gelatin-free


Reuters
December 16, 2020
Researchers said over half (51 per cent) of these doses will go to high income countries, which represent 14 per cent of the world's population


Reuters
December 13, 2020
The deal comes in a week that AstraZeneca said it was conducting further research to confirm whether its COVID-19 vaccine could be 90% effective, potentially slowing its rollout, and as a rival shot from Pfizer was launched in Britain and approved for use in the United States


Associated Press
December 12, 2020
Two vaccine candidates stumbled on Friday in the race among researchers to combat Covid-19, even as the Pfizer jab nears approval in the US


BusinessToday.In
December 10, 2020
India Stock Market Highlights Today: UltraTech Cement followed by Tata Steel, ONGC, IndusInd Bank, HDFC Bank, M&M, Infosys and Reliance Industries were among the top losers in the Sensex pack. On the other hand, Maruti, Nestle India, Titan and PowerGrid were among the gainers


Reuters
December 8, 2020
In total, Britain has ordered 40 million doses of the Pfizer/BioNTech shot. As each person requires two doses, that is enough to vaccinate 20 million people in the country of 67 million


PTI
December 7, 2020
The company is currently conducting the last stage of clinical trials for its vaccine candidate in Brazil, Turkey and Indonesia and is among the frontrunners of China' s vaccine efforts


BusinessToday.In
December 5, 2020
Confirmation of approval by National Health Regulatory Authority of Bahrain followed thorough analysis and review undertaken by authority of all available data


Niti Kiran
December 4, 2020
The RBI's revised projection stems from the recent boost in the economic revival -- both in rural as well as urban areas -- in many sectors


BusinessToday.In
December 4, 2020
India Stock Market Highlights Today: During the session, Sensex touched a lifetime high of 45,148 and Nifty hit an all-time high of 13,280


PTI
December 2, 2020
After playing a critical role in transporting essentials and medical supplies during the lockdown, SpiceXpress, has come forth to take up the responsibility of seamlessly transporting the vaccine through a specialised service called Spice Pharma Pro


Associated Press
December 2, 2020
The move makes Britain one of the first countries to begin vaccinating its population as it tries to curb Europe's deadliest COVID-19 outbreak


Manoj Sharma
December 2, 2020
Pfizer and BioNTech vaccine: The UK has already ordered 40 million doses of the Pfizer vaccine to vaccinate its 20 million population, of which around 10 million doses will be available soon


BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon


PAGES 2 OF 13  12345